Cosmetics, Generic Pharmaceutical and Marketing

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

The Pharma Data

MARCH 15, 2022

“Today’s approval of the first generic for one of the most commonly prescribed complex drug-device combination products to treat asthma and COPD is another step forward in our commitment to bring generic copies of complex drugs to the market, which can improve quality of life and help reduce the cost of treatment,” said Sally Choe, Ph.D.,

FDA Approval

FDA Approval Generic Drugs Production Drugs

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

AUGUST 2, 2023

We delve into the driving forces behind their successes and shed light on the groundbreaking research that has earned them a place among the elite in the pharmaceutical arena. is a global pharmaceutical company, working across both developed and emerging markets. 2022 Revenue: Pfizer reported an annual revenue of $100.33

Sales

Sales Manufacturing FDA Approval Life Science

Clinical Research Informer

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

Webinars

Stay Connected